Automotive Power Electronics & Semiconductor Market to reach US$117.20bn
15 October 2026.The global market is expected to expand from US$32.28bn in 2026 to US$117.20bn by 2036, at a 13.8% CAGR
The global market is expected to expand from US$32.28bn in 2026 to US$117.20bn by 2036, at a 13.8% CAGR
The global Microreactor market is projected to grow from US$482.8 million in 2027 to US$1,531.8 million by 2037, at a CAGR of 12.2%.
The Peptide Contract Manufacturing market is projected to grow at a CAGR of 12.7% by 2036
The global nuclear fuel market is projected to grow from US$36.08 billion in 2027 to US$72.24 billion by 2037.
The Biopharmaceuticals Contract Manufacturing market is projected to grow at a CAGR of 12.7% by 2036
Biologics outsourcing and demand for specialist manufacturing capacity are driving 9.7% CAGR through 2036.
The global market is expected to expand from US$142.55bn in 2026 to US$459.75bn by 2036, at a 12.4% CAGR
The global market is expected to expand from US$43.70bn in 2026 to US$166.36bn by 2036, at a 14.3% CAGR
The global market is expected to expand from US$75.67bn in 2026 to US$257.09bn by 2036, at a 13.0% CAGR
The global market is expected to expand from US$9.91bn in 2026 to US$41.58bn by 2036, at a 15.4% CAGR
The mRNA Contract Manufacturing market is projected to grow at a CAGR of 11.3% by 2036
The global Land Seismic Equipment & Acquisition Market is projected to grow from US$3.08bn in 2027 to US$5.42bn by 2037, at a CAGR of 5.8%.
The global sonar systems market is valued at US$4.59bn in 2027
Visiongain has launched an independent primary research study examining the capabilities, requirements and constraints shaping US drone manufacturing.
The global Antibody Drug Conjugates market is projected to grow at a CAGR of 11.8% by 2036
The global Antibody Drug Conjugates Contract Manufacturing market is projected to grow at a CAGR of 11.4% by 2036
The global Clinical Trial Supply and Logistics Market for Pharma is projected to grow at a CAGR of 8.7% by 2036
The market is valued at US$652.89 billion in 2026 and is projected to reach US$2,103.43 billion by 2036, expanding at a 12.4% CAGR
The global Macular Degeneration (AMD) and Other Retinal Diseases Drugs market is projected to grow at a CAGR of 9.0% by 2036
The global Active Pharmaceutical Ingredients (APIs) market is Projected to grow at a CAGR of 6.6% by 2036